Zobrazeno 1 - 10
of 173
pro vyhledávání: '"Emanuela Marcenaro"'
Autor:
Fabio Guolo, Paola Minetto, Silvia Pesce, Filippo Ballerini, Michele Cea, Marco Greppi, Matteo Bozzo, Maurizio Miglino, Elisabetta Tedone, Alessandra Bo, Alberto Serio, Silvia Luchetti, Simona Candiani, Marco Mora, Vanessa Agostini, Paolo Nozza, Genny Del Zotto, Emanuela Marcenaro, Roberto Massimo Lemoli
Publikováno v:
HemaSphere, Vol 7, p e4683875 (2023)
Externí odkaz:
https://doaj.org/article/5e1d1113c45b4380ba6df995511aa384
Autor:
Chiara M. Biatta, Michele Paudice, Marco Greppi, Veronica Parrella, Alessia Parodi, Giuseppa De Luca, Gianna Maria Cerruti, Serafina Mammoliti, Cinzia Caroti, Paola Menichini, Gilberto Fronza, Silvia Pesce, Emanuela Marcenaro, Valerio G. Vellone
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Backgroundwe evaluated the concordance between immunohistochemical p53 staining and TP53 mutations in a series of HGSOC. Moreover, we searched for prognostic differences between p53 overexpression and null expression groups.Methodspatients affected b
Externí odkaz:
https://doaj.org/article/9f4e5b0ac58246178fb58e2c8630fa81
Autor:
Federico Rebaudi, Alfredo De Rosa, Marco Greppi, Roberto Pistilli, Resi Pucci, Flavio Andrea Govoni, Paolo Iacoviello, Francesco Broccolo, Giuseppe Tomasello, Silvia Pesce, Francesco Laganà, Bernardo Bianchi, Francesca Di Gaudio, Alberto Rebaudi, Emanuela Marcenaro
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionOral squamous cell carcinoma (OSCC) accounts for approximately 90% of oral malignancies and has a 5-year mortality rate close to 50%. A consistent part (70%) of all oral cancers is diagnosed at an advanced stage since available screening
Externí odkaz:
https://doaj.org/article/ead676e5a43e4ed4adaeb1437b65af8b
Autor:
Marco Greppi, Valentina Obino, Rayan Goda, Federico Rebaudi, Simona Carlomagno, Mariella Della Chiesa, Simona Sivori, Gianluca Ubezio, Vanessa Agostini, Alessandra Bo, Silvia Pesce, Emanuela Marcenaro
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundNatural Killer cells (NKs) represent the innate counterpart of TCRαβ lymphocytes and are characterized by a high anti-tumor and an anti-viral cytotoxic activity. Recently, it has been demonstrated that NKs can express PD-1 as an additiona
Externí odkaz:
https://doaj.org/article/35381310a82a496a985bad68cfcad4ee
Autor:
Sumin Jo, Shipra Das, Alan Williams, Anne-Sophie Chretien, Thomas Pagliardini, Aude Le Roy, Jorge Postigo Fernandez, Diane Le Clerre, Billal Jahangiri, Isabelle Chion-Sotinel, Sandra Rozlan, Emilie Dessez, Agnes Gouble, Mathilde Dusséaux, Roman Galetto, Aymeric Duclert, Emanuela Marcenaro, Raynier Devillier, Daniel Olive, Philippe Duchateau, Laurent Poirot, Julien Valton
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-16 (2022)
Host versus graft reaction is a major impediment to CAR-T cell immune therapy in allogeneic settings. Authors show here that CAR-T cells, engineered to be deficient in MHC I expression but to express the NK inhibitor HLA-E, are resistant to destructi
Externí odkaz:
https://doaj.org/article/a2496c352a3244febe307778e8da45cb
Autor:
Benedetta Fiordi, Valentina Salvestrini, Gabriele Gugliotta, Fausto Castagnetti, Antonio Curti, Daniel E. Speiser, Emanuela Marcenaro, Camilla Jandus, Sara Trabanelli
Publikováno v:
Haematologica, Vol 108, Iss 9 (2023)
Chronic myeloid leukemia (CML) is a hematologic malignancy associated to an unregulated growth of myeloid cells in bone marrow (BM) and peripheral blood (PB), characterized by the BCR-ABL1 translocation. Given the known cytokine impairment in the leu
Externí odkaz:
https://doaj.org/article/72c7dcce84ce4f6cb1869d5517078d77
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
The characterization of frequency and phenotypes of natural killer (NK) cells and T cells in BAL and peripheral blood of patients with sarcoidosis was evaluated, to discriminate the differential status of these cells in these two compartments. The an
Externí odkaz:
https://doaj.org/article/2a6d7d030a70483a85f1a3d747fba8a4
Autor:
Nicoletta Provinciali, Marco Greppi, Silvia Pesce, Mariangela Rutigliani, Irene Maria Briata, Tania Buttiron Webber, Marianna Fava, Andrea DeCensi, Emanuela Marcenaro
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Despite recent advances in ovarian cancer (OC) treatment, including the introduction of bevacizumab and PARP-inhibitors, OC remains a lethal disease. Other therapeutic options are being explored, such as immunotherapy (IT), which has been proved effe
Externí odkaz:
https://doaj.org/article/f05da879a9e94a93962d686d0e4e541a
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/430f2694ffc84e6db1e3b4578c310fc9
Autor:
Mariangela Rutigliani, Matteo Bozzo, Andrea Barberis, Marco Greppi, Emanuela Anelli, Luca Castellaro, Alessandro Bonsignore, Antonio Azzinnaro, Silvia Pesce, Marco Filauro, Gian Andrea Rollandi, Patrizio Castagnola, Simona Candiani, Emanuela Marcenaro
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
We report a case of inflammatory colitis after SARS-CoV-2 infection in a patient with no additional co-morbidity who died within three weeks of hospitalization. As it is becoming increasingly clear that SARS-CoV-2 infection can cause immunological al
Externí odkaz:
https://doaj.org/article/93814d282302442f9f6428a57110941f